| 0.1814 0.005 (3.07%) | 09-13 15:47 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.21 | 1-year : | 0.25 |
| Resists | First : | 0.18 | Second : | 0.21 |
| Pivot price | 0.16 |
|||
| Supports | First : | 0.15 | Second : | 0.12 |
| MAs | MA(5) : | 0.16 |
MA(20) : | 0.16 |
| MA(100) : | 0.23  |
MA(250) : | 0.38 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 77.3 |
D(3) : | 57.7 |
| RSI | RSI(14): 55.9 |
|||
| 52-week | High : | 2.06 | Low : | 0.12 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ FOXO ] has closed It is unclear right now based on current values. 56.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.18 - 0.18 | 0.18 - 0.18 |
| Low: | 0.17 - 0.17 | 0.17 - 0.17 |
| Close: | 0.18 - 0.18 | 0.18 - 0.18 |
FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.
Thu, 12 Sep 2024
FOXO Technologies Inc. finalizes strategic acquisition - Investing.com
Thu, 12 Sep 2024
FOXO Technologies Announces Strategic Transaction and Board Expansion - TipRanks
Wed, 14 Aug 2024
FOXO Technologies Adjusts Financial Agreements with ClearThink - TipRanks
Mon, 01 Jul 2024
Foxo Technologies, Inc., Regains Compliance with SEC Reporting Requirements - Yahoo Finance
Wed, 26 Jun 2024
Biotech Company FOXO Technologies Buys Addiction Provider Myrtle Recovery Centers - Behavioral Health Business
Tue, 18 Jun 2024
FOXO Technologies Inc. Secures Up to $2.8 Million in Senior - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 1.112e+007 (%) |
| Held by Institutions | 22.7 (%) |
| Shares Short | 162 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -9.33e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -5 % |
| Return on Assets (ttm) | 675 % |
| Return on Equity (ttm) | -113.7 % |
| Qtrly Rev. Growth | 155000 % |
| Gross Profit (p.s.) | 66.98 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.26 |
| Dividend | 0 |
| Forward Dividend | 212640 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|